KPV Peptide: Gut Inflammation and IBD Research Models
PeptaBase Research Review | 2026-02-11
What Is KPV?
KPV is three amino acids: Lys-Pro-Val. It's the tail end of a larger hormone called alpha-MSH (alpha-melanocyte-stimulating hormone). Alpha-MSH controls color, energy, and immune function. KPV has the anti-inflammatory effects but is much smaller, making it easier to deliver orally or to the gut.
Melanocortin Receptor Pathway
Alpha-MSH works through melanocortin receptors on immune cells (macrophages, dendritic cells). When activated, these receptors block inflammation signals. KPV also binds melanocortin receptors, though exactly how compared to the full-length hormone is still being figured out.
KPV might also work intracellularly-by getting inside cells and doing anti-inflammatory stuff without surface receptors. Details unclear.
NF-κB Pathway Inhibition
KPV blocks NF-κB-a master switch for inflammation genes. NF-κB controls TNF, IL-1, IL-6. In gut cell models, KPV shuts down NF-κB and stops inflammatory cytokine production.
Gut Inflammation and IBD Models
KPV is tested in colitis models (DSS-induced colitis). Studies show it reduces colon damage, mucosal injury, and immune infiltration. It's a candidate for IBD research-both Crohn's and ulcerative colitis.
Oral vs. Injectable
KPV's small size makes it more stable in the gut than most peptides-potentially oral-deliverable. Studies wrap it in nanoparticles or hydrogels to protect it through the gut. Injection also studied, both systemic and directly in the colon.
Comparison with BPC-157
Both work on gut inflammation but differently. BPC-157 works through growth factor signaling (VEGF, EGF) and nitric oxide. KPV works the melanocortin-NF-κB path. Different mechanisms, different research tools.
--- For research use only. Not medical advice.